Capabilities

Services

Organized by the outcome you want — not by technique.

01

Full program · Turnkey

Send us a gene. We handle everything else.

One contract, one team, one report. You never handle samples, reagents, imports, or shipping — and for international clients, only data crosses the border. No customs.

Request a quote →

  1. 01

    Cell line sourcing

    Coriell, ATCC, or client-provided material.

  2. 02

    Reprogramming

    Fibroblasts or blood to iPSC.

  3. 03

    Full characterization

    Identity, sterility, pluripotency, karyotype.

  4. 04

    Differentiation

    To the target cell type.

  5. 05

    Disease phenotyping

    Cellular and molecular endpoints.

  6. 06

    Data analysis

    Transcriptomic and imaging readouts.

  7. 07

    Final report

    Complete dataset, methods, and interpretation.

Capacity — 2 turnkey programs per quarter

How a turnkey program runs

  1. 01

    Scope and quote

    2 business days

    You send the gene, variant, and question. We reply with a fixed quote and start date.

  2. 02

    Cell sourcing and reprogramming

    8–14 weeks

    Line sourced from Coriell or ATCC, reprogrammed to iPSC, fully characterized and banked.

  3. 03

    Differentiation and phenotyping

    6–12 weeks

    Differentiation to the target cell type, then cellular and molecular disease endpoints.

  4. 04

    Data and report

    4–6 weeks

    Transcriptomic and imaging analysis. Complete dataset, methods, and interpretation.

Why international clients use us

Importing live cells and reagents means customs delays, cold-chain shipping, and a culture that can arrive non-viable. Contracting the full chain in San Diego removes that — the line is sourced, grown, tested, and analyzed here. What crosses the border is data: a report and raw files, nothing that degrades in transit.

02

Cell models

Build a model

We generate and bank the human cell model you need, characterized to the standard a regulatory reviewer expects.

Request a quote →

iPSC reprogramming

From fibroblasts or PBMCs. Non-integrating Sendai / CytoTune.

Turnaround
6–10 weeks
Deliverable
3 clones / donor
Request a quote →

Full iPSC characterization

Mycoplasma, sterility, vector clearance, STR identity, pluripotency ICC, endogenous RT-qPCR, trilineage differentiation, karyotype.

Turnaround
4–6 weeks
Deliverable
Full QC dossier
Request a quote →

Master and working cell banking

Expanded, cryopreserved, and stored. Working banks aliquoted for direct use.

Turnaround
2–3 weeks
Deliverable
Master + working banks
Request a quote →

Cortical organoids — guided

Three protocols — semi-guided, guided, subpallial/MGE — cultured from 15 to 90+ days.

Turnaround
Organoid age + 15–25 days
Deliverable
24–48 organoids + QC report
Request a quote →

Ventricular cardiomyocytes

Wnt-modulated differentiation with lactate selection. >90% cTnT+, MLC2v+ subtype.

Turnaround
30 days with immunofluorescence
Deliverable
10M cells, live or cryo
Request a quote →

NPC and neuronal cultures

NPC expansion or NGN2 induction. MAP2+/TUJ1+ cultures, MEA-ready plating on request.

Turnaround
30 days with immunofluorescence
Deliverable
Plated batches, MEA-ready
Request a quote →

CRISPR-corrected isogenic pairs

Disease variant corrected to an otherwise identical control line.

Turnaround
3–4 months
Deliverable
Paired lines + edit confirmation
Request a quote →

03

Modality-agnostic screening

Screening program — any modality, patient-derived human tissue.

Our product is the human cell model, not the molecule. The cell does not distinguish what it receives.

Request a quote →

Modalities

  • Antisense oligonucleotides — gapmer, splice-switching, and upregulation designs
  • RNA editing oligonucleotides, including ADAR-recruiting guides
  • Therapeutic peptides
  • Small molecules
  • siRNA

Available readouts

  • Target engagement by RT-qPCR
  • Dose-response and EC50
  • Immunofluorescence
  • Confocal microscopy
  • Immunofluorescence image analysis
  • Transcriptome-wide off-target assessment by RNA-seq
  • Isoform-resolution readout showing what happened to the full transcript, not just one junction

Most screening is done in HEK293 or reporter lines. Splicing and expression context are cell-type specific — a molecule that works in a generic line may not work in neurons. We screen in the cell type that matters.

04

Computational

Analyze data

All bioinformatics is performed in-house and delivered to clients in any country. No samples required — data in, results out.

Request a quote →

Bulk RNA-seq analysis

QC, alignment, differential expression, pathway enrichment. Code and counts matrices delivered.

Turnaround
1–2 weeks
Deliverable
Counts matrix + code + report
Request a quote →

Single-cell RNA-seq

Ambient RNA and doublet removal, integration, clustering, atlas annotation, compositional testing.

Turnaround
2–4 weeks
Deliverable
Annotated object + report
Request a quote →

Aberrant splicing detection

Junction-level outlier detection with sashimi plots. Exon skipping, intron retention, cryptic splice sites.

Turnaround
3–4 weeks
Deliverable
Event table + sashimi plots
Request a quote →

Isoform structure modeling

Long-read or hybrid assembly. Per-isoform abundance and ORF impact.

Turnaround
3–5 weeks
Deliverable
Isoform GTF + abundance
Request a quote →

Methylation analysis

Array or bisulfite data. DMR detection against controls.

Turnaround
3–4 weeks
Deliverable
DMR table + report
Request a quote →

Proteomics

Processing and statistical analysis of MS datasets. Differential abundance testing.

Turnaround
3–5 weeks
Deliverable
Protein table + report
Request a quote →

Whole-genome and exome interpretation

Variant calling review, annotation, and prioritization against the disease hypothesis.

Turnaround
4–6 weeks
Deliverable
Ranked variant report
Request a quote →

Antisense oligonucleotide design

Across five mechanisms of action. 40–80 ranked candidates per target with off-target screening.

Turnaround
5–10 days
Deliverable
40–80 ranked candidates
Request a quote →

Peptide design

Sequence design against a defined target, with predicted properties.

Turnaround
5–10 days
Deliverable
Ranked candidates
Request a quote →

Target tractability assessment

Literature and dataset review of whether a target supports the modality you have in mind.

Turnaround
2–3 weeks
Deliverable
Assessment memo
Request a quote →

Published turnaround times

Planning ranges by service

iPSC reprogramming

6 to 10 weeks

Request a quote →

Full iPSC characterization

Cortical organoid production

Organoid age plus 15 to 25 days

Request a quote →

Differentiation to neurons, NPCs or cardiomyocytes, with immunofluorescence

CRISPR editing or correction

3 to 4 months

Request a quote →

Karyotype

qPCR and RT-qPCR

Sanger sequencing

Confocal microscopy

Immunofluorescence image analysis

ASO or peptide design

Bulk RNA-seq analysis

Single-cell RNA-seq analysis

Organoid timing varies with the quality of the starting iPSC line.

Single-cell timing depends on sample number.

Turnaround begins when material arrives and the deposit clears.

All cell work, drug screening, confocal microscopy, immunofluorescence image analysis, and bioinformatics are performed in-house. Sequencing and laboratory processing for bulk RNA-seq, scRNA-seq, snRNA-seq, and methylation, as well as karyotyping and digital SNP, are performed by accredited partner laboratories under our coordination. You receive a single Certificate of Analysis and deal with one party.